medication for metastatic breast cancer

Release time ：Nov-09,2024

The management of metastatic breast cancer typically involves a combination of drugs designed to control cancer progression and alleviate symptoms. These medications work through various mechanisms, such as inhibiting tumor cell growth, inducing cancer cell death, and preventing the formation of blood vessels that feed the tumor.

Chemotherapy is a common approach in treatment plans, utilizing drugs to target and kill rapidly dividing cancer cells. For breast cancers that are hormone receptor-positive, endocrine therapy is also a significant method of treatment, which works by blocking the effects of estrogen or reducing estrogen levels in the body to inhibit tumor growth. In cases of HER2-positive breast cancer, targeted therapies like trastuzumab (Herceptin) can specifically target the HER2 protein, thereby controlling tumor growth. Immunotherapy, which has been gaining momentum in recent years, activates the patient’s immune system to recognize and attack cancer cells.

When selecting a treatment plan, physicians consider a range of factors including the patient’s condition, tumor biology, and overall health status. Throughout treatment, patients should closely monitor their physical responses and promptly communicate any discomfort to their healthcare provider to allow for adjustments in the treatment plan. Additionally, maintaining healthy lifestyle habits such as a balanced diet, regular exercise, and avoiding smoking and alcohol can enhance treatment outcomes and quality of life. It is crucial for patients to adhere to their physician’s guidance, take medications as prescribed, and attend regular follow-up appointments without self-adjusting medication or dosages.